Medline Convenience Kits Recall Due to Lidocaine Quality Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 967 convenience kits nationwide because they contain Huons Lidocaine HCL Injection USP 1% ampules subject to a separate quality recall.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medline Industries, LP initiated a voluntary recall of certain convenience kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules. The action follows a recall notice issued by Huons Co., Ltd. due to quality issues identified during an FDA manufacturing inspection.
Which Products Are Affected
The recall covers 967 kits distributed nationwide under recall number Z-2536-2026. Affected products include 34 Medline Convenience Kit models such as:
- MULTIMED, 7FR, 20CM, 3L, CVC BUNDLE (ECVC5995)
- TRIPLE LUMEN CENTRAL LINE BUNDLE (ECVC2625)
- INTROFLEX 6F, 1L, TB, US (STCVC26US)
- AVA HIGH FLOW (ECVC3720)
- CDP, MM, 3L, 7F, 16CM, H (3K16H1838)
- CVC Insertion Bundle 3L 7FR 20CM (ECVC5610)
- TRIPLE LUMEN CVC INSERTION BUNDLE (ECVC3810)
- 16CM TRIPLE LUMEN 7FR INSERT BUNDLE (ECVC2555)
- CENTRAL LINE BUNDLE W/7F, 20CM, 3L (ECVC2750)
- TRIPLE LUMEN COMPLETE CATH KIT (ECVC5200)
- TRIPLE LUMEN CVC 20CM BUNDLE W/O SUTURE (ECVC7290)
- 7FR 3L 16CM CVC INSERTION BUNDLE (ECVC8215)
- CENTRAL LINE INSERTION BUNDLE (ECVC2080)
- 3L 7FR 16 CM CVC INSERTION TRAY (ECVC8165)
- VANTEX 7FR 3L 20CM CVC BUNDLE (ECVC6505)
- VANTEX 7FR, 16CM, 3L CVC BUNDLE (STCVC02)
- O.R. CVC TRIPLE LUMEN BUNDLE (ECVC1377)
- INTROFLEX 8.5FR. 1L CVC BUNDLE (CMPI851LBA)
- INTROFLEX 5F, 1L, TB, US, BAS (STCVC49US)
- CVC BUNDLE (ECVC8090)
- TRIPLE LUMEN INSERTION KIT W/CATHETER (ECVC2885)
- 3L 7FR 20CM CVC INSERTION BUNDLE (ECVC6845)
- CVC BUNDLE TRIPLE LUMEN 16CM (ECVC5540A)
- CVC INSERTION BUNDLE (ECVC1120)
- VANTEX 7FR 3L 16CM CVC BUNDLE W/US (ECVC8075, ECVC7945)
- CENTRAL LINE BUNDLE W/7F, 16CM, 3L (ECVC2745) Each kit carries specific lot numbers and UDI-DI codes as detailed in FDA records. The classification is Class II.
What You Should Do
Consumers and healthcare facilities should stop using the affected kits and contact Medline Industries, LP for return or further instructions.
Why This Matters
The recalled kits are used for central venous catheter insertions and contain lidocaine ampules that may not meet quality standards.
Source
FDA Enforcement Report, recall Z-2536-2026, Medline Industries, LP, Northfield, IL.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (2,157 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.